An essential enzyme in the pathophysiology of bladder cancer, CYP1A2 is involved in the activation of the two main known bladder carcinogens, aromatic amines (AAs) and polycyclic aromatic hydrocarbons (PAHs) [11–14]. Here, CYP1A2 is linked to urinary bladder carcinoma.